000 | 01990 a2200565 4500 | ||
---|---|---|---|
005 | 20250518012400.0 | ||
264 | 0 | _c20191121 | |
008 | 201911s 0 0 eng d | ||
022 | _a1538-7445 | ||
024 | 7 |
_a10.1158/0008-5472.CAN-18-1078 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWarda, Walid | |
245 | 0 | 0 |
_aCML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor-Engineered T Cells. _h[electronic resource] |
260 |
_bCancer research _c02 2019 |
||
300 |
_a663-675 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
650 | 0 | 4 |
_aCell Engineering _xmethods |
650 | 0 | 4 | _aCytotoxicity, Immunologic |
650 | 0 | 4 |
_aHematopoietic Stem Cells _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotherapy, Adoptive _xmethods |
650 | 0 | 4 |
_aInterleukin-1 Receptor Accessory Protein _ximmunology |
650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _ximmunology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 |
_aReceptors, Chimeric Antigen _ximmunology |
650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aLarosa, Fabrice | |
700 | 1 | _aNeto Da Rocha, Mathieu | |
700 | 1 | _aTrad, Rim | |
700 | 1 | _aDeconinck, Eric | |
700 | 1 | _aFajloun, Ziad | |
700 | 1 | _aFaure, Cyril | |
700 | 1 | _aCaillot, Denis | |
700 | 1 | _aMoldovan, Marius | |
700 | 1 | _aValmary-Degano, Severine | |
700 | 1 | _aBiichle, Sabeha | |
700 | 1 | _aDaguindau, Etienne | |
700 | 1 | _aGarnache-Ottou, Francine | |
700 | 1 | _aTabruyn, Sebastien | |
700 | 1 | _aAdotevi, Olivier | |
700 | 1 | _aDeschamps, Marina | |
700 | 1 | _aFerrand, Christophe | |
773 | 0 |
_tCancer research _gvol. 79 _gno. 3 _gp. 663-675 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/0008-5472.CAN-18-1078 _zAvailable from publisher's website |
999 |
_c29128448 _d29128448 |